when given intraperitoneally to the transplantable tumor bearing mice at dose of 75-125 mg/kg , the tumor inhibition rate was more than 88.8 % in ehrilich ascitic cancer ( eac ) or ascitic form of hepatoma ( hepa ) and more than 49.6 % in solid hepatoma ( heps ) .
C0027651
tumor
C0006826
cancer